3.8 Review

Neuropharmacology of Sleep and Wakefulness: 2012 Update

期刊

SLEEP MEDICINE CLINICS
卷 7, 期 3, 页码 469-+

出版社

ELSEVIER INC
DOI: 10.1016/j.jsmc.2012.06.010

关键词

Neurotransmitters; Receptors; Translational research; Drug development

资金

  1. National Institutes of Health [HL40881, HL65272, MH45361]
  2. Department of Anesthesiology

向作者/读者索取更多资源

The development of sedative/hypnotic molecules has been empiric rather than rational. The empiric approach has produced clinically useful drugs, but for no drug is the mechanism of action completely understood. All available sedative/hypnotic medications have unwanted side effects, and none of these medications creates a sleep architecture that is identical to the architecture of naturally occurring sleep. This article reviews recent advances in research aiming to elucidate the neurochemical mechanisms regulating sleep and wakefulness. One promise of rational drug design is that understanding the mechanisms of sedative/hypnotic action will significantly enhance drug safety and efficacy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据